Vizhli Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.19%
- Profit Growth 65.72%
- Ebitda 254.60%
- Net Worth 31.83%
- Total Assets 8.23%
About Vizhli Pharma
Vizhli Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 September 2010 and has a history of 14 years and four months. Its registered office is in Namakkal, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Murugesan Sankarasubramanian, Sivakumar Venkataraman, Ramesh Palaniappan, and One other member serve as directors at the Company.
Company Details
-
Location
Namakkal, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52310TZ2010PTC016390
-
Company No.
016390
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
What products or services does Vizhli Pharma Private Limited offer?
Vizhli Pharma Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Vizhli Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murugesan Sankarasubramanian
|
Director | 22-Sep-2010 | Current |
|
Sivakumar Venkataraman
|
Director | 22-Sep-2010 | Current |
|
Ramesh Palaniappan
|
Director | 22-Sep-2010 | Current |
|
Ragupathy Appavu
|
Director | 22-Sep-2010 | Current |
Financial Performance of Vizhli Pharma.
Vizhli Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.19% increase. The company also saw a substantial improvement in profitability, with a 65.72% increase in profit. The company's net worth Soared by an impressive increase of 31.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vizhli Pharma?
In 2017, Vizhli Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vizhli Pharma?
Unlock and access historical data on people associated with Vizhli Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vizhli Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vizhli Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.